Third Department of Internal Medicine, General University Hospital, U nemocnice 1, 128 08 Prague, Czech Republic.
Physiol Res. 2009;58(5):613-621. doi: 10.33549/physiolres.931614. Epub 2008 Nov 4.
More than 50 % of end-stage renal disease (ESRD) patients treated by chronic hemodialysis die from cardiovascular diseases, including congestive heart failure (CHF). The incidence of CHF is rising in both general and ESRD population. However, the mechanisms, which lead to the development of CHF in dialyzed patients, differ considerably. First, there are several factors leading to increase of the left ventricular afterload: volume overload between dialyses, hypertension, increased arterial stiffness, anemia, vascular access flow (arteriovenous fistula) and sympathetic activation. Second, hypertension, left ventricular hypertrophy, anemia and frequently present coronary artery disease worsen myocardial oxygenation. The combination of these factors explains the high incidence of CHF in dialyzed patients and their roles are reviewed in this article.
超过 50%的接受慢性血液透析治疗的终末期肾病 (ESRD) 患者死于心血管疾病,包括充血性心力衰竭 (CHF)。充血性心力衰竭的发病率在普通人群和 ESRD 人群中都在上升。然而,导致透析患者发生充血性心力衰竭的机制有很大的不同。首先,有几个因素导致左心室后负荷增加:透析间期的容量超负荷、高血压、动脉僵硬增加、贫血、血管通路流量(动静脉瘘)和交感神经激活。其次,高血压、左心室肥厚、贫血和经常存在的冠状动脉疾病恶化心肌氧合。这些因素的组合解释了透析患者中充血性心力衰竭的高发病率,本文综述了它们的作用。